Get started
Author

Shota Yanagida

An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
2023 · Emiko Urano, Yumi Itoh, et al. · Science Translational Medicine · 45
PDF
SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium
2022 · Shigeru Yamada, Takamasa Noda, et al. · Journal of Pharmacological Sciences · 32
PDF
Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes
2021 · Shota Yanagida, Ayano Satsuka, et al. · The Journal of Toxicological Sciences · 27
PDF
Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer
2022 · Naoya Hirata, Shigeru Yamada, et al. · International Journal of Molecular Sciences · 26
PDF
SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway
2024 · Shigeru Yamada, Tadahiro Hashita, et al. · Fluids and Barriers of the CNS · 22
PDF
FTY720 Inhibits Expansion of Breast Cancer Stem Cells via PP2A Activation
2021 · Naoya Hirata, Shigeru Yamada, et al. · International Journal of Molecular Sciences · 22
PDF
Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
2021 · Shota Yanagida, Ayano Satsuka, et al. · Toxicological Sciences · 16
PDF
Contractility assessment using aligned human iPSC-derived cardiomyocytes
2024 · Ayano Satsuka, Alexandre J.S. Ribeiro, et al. · Journal of Pharmacological and Toxicological Methods · 11
Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
2023 · Akiko Ogawa, Seiya Ohira, et al. · Communications Biology · 9
PDF
Contractility assessment of human iPSC-derived cardiomyocytes by using a motion vector system and measuring cell impedance
2022 · Ayano Satsuka, Sayo Hayashi, et al. · Journal of Pharmacological and Toxicological Methods · 8
Transforming Growth Factor Beta Promotes the Expansion of Cancer Stem Cells via S1PR3 by Ligand-Independent Notch Activation
2022 · Naoya Hirata, Shigeru Yamada, et al. · Biological and Pharmaceutical Bulletin · 6
PDF
In Vitro Assessment of Drug‐Induced Liver Injury Using Three‐Dimensional Cultured HepaSH Cells Derived From Chimeric Mouse Model With Humanized Liver
2025 · Xingming Liu, Yuichiro Higuchi, et al. · Journal of Applied Toxicology · 5
Cardiotoxicity Assessment of EGFR Tyrosine Kinase Inhibitors Using Human iPS Cell‐Derived Cardiomyocytes and FDA Adverse Events Reporting System
2025 · Shota Yanagida, Hiroyuki Kawagishi, et al. · Clinical and Translational Science · 4
PDF
Proarrhythmia Risk Assessment Using Electro-Mechanical Window in Human iPS Cell-Derived Cardiomyocytes
2022 · Shota Yanagida, Ayano Satsuka, et al. · Biological and Pharmaceutical Bulletin · 3
PDF
Prediction of Cardiac Toxicity by Anti-cancer Drugs Using iPSC Cardiomyocytes
2024 · Shota Yanagida, Yasunari Kanda · YAKUGAKU ZASSHI · 2
PDF
Cardiotoxicity risk assessment of anti-cancer drugs and future perspectives
2024 · Shota Yanagida, Hiroyuki Kawagishi, et al. · Folia Pharmacologica Japonica · 2
PDF
Comparison of live-cell imaging-based contractility analysis using human iPS cell-derived cardiomyocytes
2025 · Hiroyuki Kawagishi, Shota Yanagida, et al. · Journal of Pharmacological and Toxicological Methods · 1
Global trends in drug development using alternatives to animal testing
2026 · Shota Yanagida, Hiroyuki Kawagishi, et al. · Folia Pharmacologica Japonica
Evaluation of drug-induced liver injury using 3D-cultured HepaSH cells derived from chimeric mice with humanized liver
2026 · Hiroyuki Kawagishi, Xingming Liu, et al. · Journal of Pharmacological and Toxicological Methods
Assessment of cardiac contractility using aligned human iPS cell-derived cardiomyocytes
2025 · Hiroyuki Kawagishi, Ayano Satsuka, et al. · Journal of Pharmacological and Toxicological Methods
Assessment of cardiotoxicity induced by EGFR-tyrosine kinase inhibitors using human iPSC-derived cardiomyocytes
2025 · Shota Yanagida, Hiroyuki Kawagishi, et al. · Journal of Pharmacological and Toxicological Methods
Drug Development Using Human iPSC-Derived Cardiomyocytes and Future Perspectives
2024 · Hiroyuki Kawagishi, Shota Yanagida, et al. · Elsevier eBooks
Cardiotoxicity assessment of VEGFR-tyrosine kinase inhibitors by human iPSC cardiomyocyte and pharmacovigilance analysis
2023 · Hiroyuki Kawagishi, Shota Yanagida, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Cardiac contractility assessment of BCR-ABL tyrosine kinase inhibitors using human iPS cell-derived cardiomyocytes and real-world database.
2023 · Shota Yanagida, Hiroyuki Kawagishi, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Chronic toxicity assessment of BCR-ABL tyrosine kinase inhibitors using human-induced pluripotent stem cell-derived cardiomyocytes
2022 · Hayashi Sayo, Ayano Satsuka, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Works count: 41
Citation count: 241
H-index: 9
I10-index: 8
Year
Topic
Type